氯沙坦对实验性肝纤维化模型大鼠的作用

山东大学学报(医学版) ›› 2013, Vol. 51 ›› Issue (3): 27-31.

氯沙坦对实验性肝纤维化模型大鼠的作用

杨艳1，阎春英1，陈旭2，林晓燕3，王来城4，石军1

山东大学附属省立医院 1. 感染性疾病科肝病区； 2. 心内科； 3. 病理科； 4. 中心实验室，济南 250021

收稿日期:2012-09-27 出版日期:2013-03-10 发布日期:2013-03-10
通讯作者: 石军（1966- ），男，博士，副教授，主要从事病毒性肝炎、脂肪肝、肝纤维化、肝硬化及肝癌的研究。E-mail：sdshij@yahoo.com.cn
作者简介:杨艳(1988- )，女，硕士研究生，主要从事肝纤维化的研究。E-mail: yangyan880106@163.com

Effect of losartan on the rat model of experimental hepatic fibrosis

YANG Yan1, YAN Chun-ying1, CHEN Xu2, LIN Xiao-yan3, WANG Lai-cheng4, SHI Jun1

1.Department of Liver Diseases; 2.Department of Cardiology; 3.Department of Pathology;
4.Central Laboratory, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China

Received:2012-09-27 Online:2013-03-10 Published:2013-03-10

摘要/Abstract

摘要：

目的研究氯沙坦对40%CCL4诱导的大鼠肝脏纤维化的影响。方法制备CCL4诱导的大鼠肝纤维化模型，同时给予氯沙坦灌胃，共6周，分别取血和肝组织，检测血清天冬氨酸转氨酶(AST)、丙氨酸氨基转移酶(ALT)；光镜下观察肝组织病理改变;偏光显微镜下观察肝组织纤维化的程度；免疫组化检测Ⅰ、Ⅲ型胶原的表达；检测大鼠肝组织中AngⅡ、AT1R mRNA表达。结果与模型组比较，氯沙坦干预组炎症反应、纤维化程度明显减轻，Ⅰ、Ⅲ型胶原的表达明显减少( P<0.05)，肝功能改善;肝组织中AngⅡ、AT1R mRNA表达降低(P<0.05)。结论氯沙坦可能通过降低AngⅡ、AT1R的表达，而对CCL4诱导的大鼠肝纤维化起到一定的保护治疗作用。

关键词: 氯沙坦；肝纤维化；血管紧张素Ⅱ；大鼠，Wistar

Abstract:

Objective To explore the effect of angiotensin Ⅱ receptor blocker losartan on rats hepatic fibrosis induced by carbon tetrachloride (CCL4). Methods Hepatic fibrosis was induced in rats by intraperitoneal injection of carbon tetrachloride(40%). Meanwhile, losartan was given to the fibrosis+losartan intervention group rats(daily gavage), and sterile saline was given to the control rats for 6 weeks. Blood and liver tissue samples were taken for detecting aspartate aminotransferase (AST) and alanine aminotransferase (ALT).The pathological changes and fibrosis extent of liver tissues were observed by light microscope and polarizing microscope respectively. Collagen type I and collagen type Ⅲ were detected by immunohistochemistry.Liver AngⅡ and AT1R mRNA expressions were determined by RT-PCR. Results Compared with those of the model group, liver inflammation and hepatic fibrosis were significantly reduced in the fibrosis+losartan intervention group;collagen type I and collagen type Ⅲ content were lowered in the fibrosis+losartan intervention group(P<0.05); the liver function was improved significantly.Meanwhile,the levels of AngⅡand AT1R mRNA in liver tissues also decreased(P<0.05). Conclusion Losartan may has a therapeutic effect on carbon tetrachloride-induced liver fibrosis rats by reducing the expressions of liver AngⅡand AT1R.

Key words: Losartan; Hepatic fibrosis; Angiotensin Ⅱ; Rats, Wistar

中图分类号:

R575

杨艳1，阎春英1，陈旭2，林晓燕3，王来城4，石军1. 氯沙坦对实验性肝纤维化模型大鼠的作用[J]. 山东大学学报(医学版), 2013, 51(3): 27-31.

YANG Yan1, YAN Chun-ying1, CHEN Xu2, LIN Xiao-yan3, WANG Lai-cheng4, SHI Jun1. Effect of losartan on the rat model of experimental hepatic fibrosis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 27-31.

参考文献

相关文章 6

[1]	刘莉1，阎明2，李强1，张海涛1. 大鼠酒精性肝损伤超微结构观察[J]. 山东大学学报(医学版), 2012, 50(8): 31-.
[2]	赵正斌1，薛双林2，张立婷1，李俊峰1，赵荣荣1，周海莲3，陈红1. 原花青素对瘦素诱导肝星状细胞增殖和TIMP-1产生的影响[J]. 山东大学学报(医学版), 2012, 50(7): 46-.
[3]	阎春英1，石军1，郝菁华1，张捷2，孙林林1，任万华1. 低分子肝素对酒精性肝损伤大鼠的影响[J]. 山东大学学报(医学版), 2011, 49(3): 41-45.
[4]	阎春英1，石军1，郝菁华1，张捷2，孙林林1，任万华1. 低分子肝素对酒精性肝损伤大鼠的影响[J]. 山东大学学报(医学版), 2011, 49(3): 41-45.
[5]	孙林林，石军郝菁华，任万华. 低分子肝素对高脂饮食大鼠非酒精性脂肪性肝炎模型的影响[J]. 山东大学学报(医学版), 2010, 48(11): 58-62.
[6]	李森林，赵景润，任晓燕，马青竹，谢佳平，李振方，郎翠翠. 罗格列酮对肝星状细胞MMP2、TIMP1mRNA表达的影响[J]. 山东大学学报(医学版), 2009, 47(11): 74-75.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed